International Business Machines teams up with e& to launch enterprise-grade agentic AI for compliance, policy, and risk, powered by watsonx Orchestrate.

Micron Technology, (NASDAQ: MU), a prominent name in memory and storage solutions, experienced a significant surge in trading volume. The trigger for this was the groundbreaking of its New York megafab, an event further enhanced by robust insider purchases and an optimistic narrative around an AI-driven memory cycle.

Tiziana Life Sciences Ltd (NASDAQ:TLSA) said on Tuesday that a peer-reviewed study of its experimental intranasal therapy for secondary progressive multiple sclerosis (SPMS) has been published in the journal Neurology Neuroimmunology & Neuroinflammation. The study, titled “Nasal Foralumab for the Treatment of Progression Independent of Relapses in Patients with Non-active Secondary Progressive Multiple Sclerosis,” evaluated intranasal foralumab, a fully human anti-CD3 monoclonal antibody, in 10 patients with non-active SPMS (na-SPMS) who continued to progress despite prior B-cell therapies.

The wealthy and powerful men and women of Davos this week brace for President Trump's appearance tomorrow at the 2026 World Economic Forum.

Here, we have picked four technology stocks, SNDK, APH, ASML and GLW, which are likely to pull off earnings surprises this earnings season.

Zeta is poised for a strong 2026, driven by its OpenAI partnership and a natural acceleration in revenue growth. ZETA targets 35% y/y revenue growth and $1.7B in sales, with organic growth rates expected to exceed 20% in 2026. Trading at 22x forward free cash flow, ZETA offers compelling risk-reward as fundamentals and narrative improve.

StubHub share price has fallen significantly after its September 2025 IPO, rebounding slightly since December. Known for its reselling marketplace, StubHub now wants a piece of the Direct Issuance market. This move quadruples the current available market. Even with modest share gain in these new ventures, the company can meaningfully grow Revenue and EPS by more than +30% in the coming years.

GWRE plunges 12.4% in a year as shares hit a 52-week low, even as cloud adoption, ARR growth and AI investments remain strong.

DENVER, Jan. 20, 2026 /PRNewswire/ - Ovintiv Inc. (NYSE: OVV) (TSX: OVV) today announced plans to hold its 2025 fourth quarter and year-end results conference call at 8:00 a.m. MT, on Tuesday February 24, 2026.

Major bank upgrades economic outlook with 2.8% GDP growth forecast for 2026, above market consensus. BofA sees bullish signs in consumer spending.

Strategic Alliance Delivers Multi-Tier Waterfall Lending Platform to Thousands of Retailers of All Sizes At No Additional Cost Strategic Alliance Delivers Multi-Tier Waterfall Lending Platform to Thousands of Retailers of All Sizes At No Additional Cost

NEW YORK, Jan. 20, 2026 (GLOBE NEWSWIRE) -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Stride, Inc. (NYSE: LRN) breached their fiduciary duties to shareholders. According to a federal securities lawsuit, Insiders at Stride caused the company to misrepresent or fail to disclose that Stride was: (1) inflating enrollment numbers by retaining “ghost students”; (2) cutting staffing costs by assigning teachers' caseloads far beyond the required statutory limits; (3) ignoring compliance requirements, including background checks and licensure laws for its employees, and ignoring federally mandated special education services to students; (4) …

Compass Therapeutics remains a 'Buy,' but valuation above $1B stretches risk/reward as it awaits pivotal clinical catalysts. Tovecimig's early data in biliary tract and refractory colorectal cancers show promise, with key COMPANION-002 updates expected late Q1 2026. CMPX's cash runway extends into 2028, supporting continued clinical progress and mitigating near-term financing risk.

Applied Materials' expanding HBM, NAND and advanced packaging tools contrast with ASML Holding's EUV-led shift in semiconductor patterning.

Mosaic flags weak Q4 fertilizer demand, with phosphate shipments down 20% YoY and preliminary volumes of 1.3Mt phosphate and 2.2Mt potash.

Estee Lauder was sued by a self-described "disruptive" startup that accused the cosmetics giant of effectively putting it out of business by stealing technology to boost sales from jet-setting travelers in hotels.

NEW YORK, Jan. 20, 2026 (GLOBE NEWSWIRE) -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Freeport-McMoran Inc. (NYSE: FCX) breached their fiduciary duties to shareholders.

RADNOR, Pa.--(BUSINESS WIRE)-- #classaction--The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities fraud class action lawsuit has been filed against Bath & Body Works, Inc. (“Bath & Body Works”) (NYSE: BBWI) on behalf of those who purchased or otherwise acquired Bath & Body Works securities between June 4, 2024, and November 19, 2025, inclusive (the “Class Period”). The lead plaintiff deadline is March 13, 2026. Action: Securities fraud class act.

The SPDR Portfolio Europe ETF has slipped as a combination of geopolitical tensions over Greenland and no progress on a ceasefire in Ukraine weighs on investor sentiment. I remain hopeful that we will see de-escalation on both fronts, likely signaling that the pullback in SPEU is a buying opportunity. SPEU holdings remain notably cheaper relative to the S&P 500 even if we account for lower European GDP growth.

Bank stocks haven't exactly been the darlings of income investors over the past few years, for understandable reasons.